nonobaddog
Grandmaster
Why aren't there any good studies, ones that don't get thrown out for various reasons, on ivermectin as a prophylactic?COVID-19 Guideline, Part 1: Treatment and Management
IDSA has developed living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection. Summarized here are the recommendations with comments related to the...www.idsociety.org
Here's a summary of what infectious disease society is recommending. They discuss many options and give evidence why they support or recommend against particular therapies.
To me it makes little sense to not provide steroids to those who are at risk. But since the majority do not progress to severe disease, it's difficult to recommend that everyone take them. Studies did show harm if given to lower acuity patients.
What evidence do you have that we should be doing things differently? I'm genuinely curious. I hate that we have little to offer and now MAB likely is much less effective due to spike protein mutations.
And why monoclonal? Why not give a slurry of various antibodies?
I see studies where the patients are hospitalized and some even on respirators. Maybe that is too late to protect the patients from hospitalization since they are already there.